Colestilan

Chemical formula: C₇H₁₁ClN₂O  Molecular mass: 174.056 g/mol 

Therapeutic indications

Colestilan is indicated for:

Hyperphosphataemia in patients with Chronic Kidney Disease (CKD) Stage 5

Population group: only adults (18 - 65 years old)

Colestilan is indicated for the treatment of hyperphosphataemia in adult patients with Chronic Kidney Disease (CKD) Stage 5 receiving haemodialysis or peritoneal dialysis.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Contraindications

Colestilan is contraindicated in the following cases:

Severe hepatic impairment

Hepatic failure stage IV

Bowel obstruction

Intestinal obstruction

Hyperparathyroidism

Hyperparathyroidism

Get recommendations

Factors such as age, gender, and health history are evaluated to create a personalized medication regimen.

Ask the Reasoner

Related medicines

Summary of Product Characteristics (SPC) 2015: BINDREN Film-coated tablet
< Previous: Overview
Next: Precautions >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈